10:00 am US Eastern Time
Goodson presentation slides
Download the PDF
Paper: Activation of the mTOR pathway by low levels of xenoestrogens in breast epithelial cells from high-risk women Goodson, et al
Paper: Bisphenol A Induces a Profile of Tumor Aggressiveness in High-Risk Cells from Breast Cancer Patients
Dairkee, et al
American Association for Cancer Research, 2008
Abstract: Adverse Health Outcomes in Women Exposed In Utero to Diethylstilbestrol
NEJM, October 2011
Referenced by Ted Schettler during his science introduction on the call.
Article: Testing Chemicals for Effects on Breast Development, Lactation, and Cancer (PDF)
Environmental Health Perspectives, August 2011
Report: Urgent Unanswered Questions About Breast Cancer (PDF)
California Breast Cancer Research Program, 2010
Article: Breast Cancer Fund Study: Science or Class Warfare?
Trevor Butterworth, Forbes
September 21, 2011
San Francisco Medical Society blog: What's Not on the Can's Label (Editorial on Bisphenol A featuring SFMS member)
Widely-noted research published recently indicated that the presence of chemicals like BPA and methylparaben can interfere with commonly-used breast cancer therapies. On October 27, 2011 this call featured the lead author of that study, William Goodson, MD as well as Mhel Kavanaugh-Lynch, MD, MPH, who discussed health policy opportunities based on this research and other studies associating chemical exposures with breast cancer.
Ted Schettler, MD, MPH also provided a brief update on new science relevant to this topic.
This call was co-sponsored by CHE's Breast Cancer Working Group.
The call was facilitated by Steve Heilig, San Francisco Medical Society.